- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- Public filings
- Bulk ZIP download
- Dashboard access (1 year)
Key Metrics
Company Health Scores
Health scores for Rene Pharmaceuticals Private Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
About Rene Pharmaceuticals Private Limited
Rene Pharmaceuticals Private Limited is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U51101MH2016PTC274524). Business overview includes Pharma (Pharmaceutical Retailers & Distributors), incorporated on March 17, 2016 (10+ years old), headquartered in Mumbai, Maharashtra, India. The company is currently Active with Active Compliant compliance status. For FY 2022, the company reported revenue of ₹13.25 Cr with a profit of ₹51.26 Lakh. It has 2 active directors. The company employs approximately 27 people.
- Location 206 Dimple Arcade Extension Building 10 Asha Nagar, Kandivali East, Mumbai, Maharashtra - 400101
- Website renepharmaceuticals.in
Financial Performance of Rene Pharmaceuticals Private Limited
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,20,083.04 cr | 2,35,431.21 cr | 2,51,890.00 cr | 2,18,400.00 cr | 1,95,200.00 cr | 1,72,000.00 cr | 1,59,000.00 cr |
| Profit/Loss | 13,969.70 cr | 4,810.00 cr | 12,200.00 cr | 9,100.00 cr | -8,200.00 cr | 3,200.00 cr | 5,100.00 cr |
| Cash & Bank Balance | 38,200.00 cr | 35,100.00 cr | 32,000.00 cr | 28,500.00 cr | 25,200.00 cr | 22,000.00 cr | 19,800.00 cr |
| Net Worth | 1,26,731.94 cr | 1,37,500.00 cr | 1,40,200.00 cr | 1,28,000.00 cr | 1,15,000.00 cr | 1,02,000.00 cr | 95,000.00 cr |
| EBITDA | 27,865.49 cr | 29,800.00 cr | 30,200.00 cr | 27,000.00 cr | 24,500.00 cr | 22,000.00 cr | 20,100.00 cr |
Financial Ratios
Values in Crores (Cr) - illustrative trend
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Profit Margin | 10.54 | 3.20 | 2.10 | 1.80 | 0.50 |
| Debt to EBITDA | 2.14 | 1.90 | 1.70 | 1.50 | 1.20 |
| Interest Coverage Ratio | 0.47 | 0.50 | 0.45 | 0.40 | 0.35 |
| Debt to Equity | 0.88 | 0.90 | 0.85 | 0.80 | 0.75 |
| Return on Equity | 12.10 | 3.00 | 2.00 | 1.50 | 0.20 |
| Current Ratio | 1.20 | 1.15 | 1.10 | 1.05 | 0.99 |
| Quick Ratio | 0.95 | 0.92 | 0.88 | 0.85 | 0.80 |
| EBITDA Margin | 12.00 | 10.00 | 8.00 | 7.00 | 5.00 |
| Return on Capital Employed | 8.00 | 2.00 | 1.00 | 0.20 | 0.00 |
| Earning Per Share | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPFO Establishments (1)
Current Directors (2)
Charges Overview
| Lender | Amount | Status |
|---|---|---|
|
Axis Bank Limited
Creation Date: 05 Jan 2024
|
2.00 cr | Open |
|
Hdfc Bank Limited
Creation Date: 21 Oct 2023
|
31.63 Lakh | Open |
|
Axis Bank Limited
Creation Date: 25 Jan 2022
|
1.65 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Trade | - | 100 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases
- Narendra Parshuram Shelar
- Nalamati Arun
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.